Literature DB >> 4022206

Lowered protein content of tissue fluid in patients with the nephrotic syndrome: observations during disease and recovery.

H A Koomans, W Kortlandt, A B Geers, E J Dorhout Mees.   

Abstract

To find out why most patients with the nephrotic syndrome maintain a normal blood volume despite a reduced plasma colloid osmotic pressure (COP), we measured the transcapillary (plasma-tissue fluid) COP difference in 12 patients with the nephrotic syndrome, as well as in 6 patients during complete (n = 3) and partial (n = 3) recovery. Subcutaneous nylon wicks were used to collect tissue fluid. The albumin content was also measured. The albumin content and COP were lowered in both plasma and tissue fluid in the nephrotic phase, and rose gradually during recovery. During these changes the transcapillary COP difference only rose slightly: from 6.2 +/- 1.7 mm Hg when the plasma COP was below 10 mm Hg (n = 11) to 8.7 +/- 1.5 mm Hg when the plasma COP exceeded 20 mm Hg (n = 12). These observations indicate that in hypoproteinemia preservation of the intravascular volume is strongly dependent on maintenance of the difference in oncotic pressure across the capillary wall.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4022206     DOI: 10.1159/000183505

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  9 in total

Review 1.  [Volume retention in heart failure, nephrotic syndrome, and liver cirrhosis].

Authors:  G H Heine; U Sester; H Köhler
Journal:  Internist (Berl)       Date:  2006-11       Impact factor: 0.743

Review 2.  Intra- and extrarenal factors of oedema formation in the nephrotic syndrome.

Authors:  T Tulassay; W Rascher; K Schärer
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

3.  Is edema in minimal change disease of childhood really hypovolemic?

Authors:  Yilmaz Tabel; Ilke Mungan; Cemsit Karakurt; Gulendam Kocak; Serdal Gungor
Journal:  Int Urol Nephrol       Date:  2008-04-15       Impact factor: 2.370

Review 4.  Pharmacokinetic changes in patients with oedema.

Authors:  B Vrhovac; N Sarapa; I Bakran; M Huic; V Macolic-Sarinic; I Francetic; A Wolf-Coporda; F Plavsic
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

Review 5.  Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications.

Authors:  Alain Doucet; Guillaume Favre; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2007-06-07       Impact factor: 3.714

6.  Oxidative Stress and Nuclear Factor κB (NF-κB) Increase Peritoneal Filtration and Contribute to Ascites Formation in Nephrotic Syndrome.

Authors:  Khalil Udwan; Gaëlle Brideau; Marc Fila; Aurélie Edwards; Bruno Vogt; Alain Doucet
Journal:  J Biol Chem       Date:  2016-03-31       Impact factor: 5.157

7.  Effect of topical anaesthetics on interstitial colloid osmotic pressure in human subcutaneous tissue sampled by wick technique.

Authors:  Hans Jørgen Timm Guthe; Torbjørn Nedrebø; Olav Tenstad; Helge Wiig; Ansgar Berg
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

8.  Albumin is an interface between blood plasma and cell membrane, and not just a sponge.

Authors:  Jens van de Wouw; Jaap A Joles
Journal:  Clin Kidney J       Date:  2021-10-05

Review 9.  Pathophysiology, Evaluation, and Management of Edema in Childhood Nephrotic Syndrome.

Authors:  Demetrius Ellis
Journal:  Front Pediatr       Date:  2016-01-11       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.